ATE347371T1 - Zusammenstellungen zur erhöhung der darmabsoption von fetten - Google Patents

Zusammenstellungen zur erhöhung der darmabsoption von fetten

Info

Publication number
ATE347371T1
ATE347371T1 AT99944090T AT99944090T ATE347371T1 AT E347371 T1 ATE347371 T1 AT E347371T1 AT 99944090 T AT99944090 T AT 99944090T AT 99944090 T AT99944090 T AT 99944090T AT E347371 T1 ATE347371 T1 AT E347371T1
Authority
AT
Austria
Prior art keywords
absoption
fat
compositions
increase intestinal
intestine
Prior art date
Application number
AT99944090T
Other languages
German (de)
English (en)
Inventor
David W Yesair
Original Assignee
Biomolecular Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomolecular Products Inc filed Critical Biomolecular Products Inc
Application granted granted Critical
Publication of ATE347371T1 publication Critical patent/ATE347371T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/465Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y301/00Hydrolases acting on ester bonds (3.1)
    • C12Y301/01Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01004Phospholipase A2 (3.1.1.4)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT99944090T 1998-09-08 1999-09-07 Zusammenstellungen zur erhöhung der darmabsoption von fetten ATE347371T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9943098P 1998-09-08 1998-09-08

Publications (1)

Publication Number Publication Date
ATE347371T1 true ATE347371T1 (de) 2006-12-15

Family

ID=22274976

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99944090T ATE347371T1 (de) 1998-09-08 1999-09-07 Zusammenstellungen zur erhöhung der darmabsoption von fetten

Country Status (13)

Country Link
US (1) US6426069B1 (https=)
EP (1) EP1119360B1 (https=)
JP (1) JP4700193B2 (https=)
CN (1) CN1321089A (https=)
AT (1) ATE347371T1 (https=)
AU (1) AU771901B2 (https=)
CA (1) CA2343116C (https=)
DE (1) DE69934325T2 (https=)
IL (2) IL141801A0 (https=)
NO (1) NO20011173L (https=)
NZ (1) NZ510536A (https=)
WO (1) WO2000013689A1 (https=)
ZA (1) ZA200102268B (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL161178A0 (en) * 2001-10-11 2004-08-31 Biomolecular Products Inc MODIFICATIONS OF SOLID 3-sn-PHOSPHOGLYCERIDES
DE60238663D1 (de) 2002-04-05 2011-02-03 Nestle Sa Zusammensetzungen und Verfahren zur Verbesserung von Lipidassimilation in Haustieren
DE10217555A1 (de) * 2002-04-19 2004-02-19 Degussa Bioactives Deutschland Gmbh Physiologisch verträgliche, Phospholipid-haltige, stabile und harte Matrix
JP2006518384A (ja) * 2003-01-31 2006-08-10 チルドレンズ・ホスピタル・ロス・アンジエルス 改善されたバイオアベイラビリティを有するフェンレチニドの経口組成物、およびその使用方法
US7758884B2 (en) * 2005-01-28 2010-07-20 Kemin Industries, Inc. Formulation for increasing the deposition of dietary carotenoids in eggs
EP1688049A1 (de) * 2005-02-03 2006-08-09 findusFit Sportdiätetika GmbH Diätetisches Lebensmittel
FR2918846B1 (fr) * 2007-07-20 2013-07-26 Isl Innovation Sante Lipides Composition alimentaire pour ameliorer la digestibilite des lipides alimentaires
US10463229B2 (en) * 2010-10-22 2019-11-05 Fukuoka University Endoscopic observation method and composition for improving diagnostic performance involving applying useful white opaque substance to diagnosis of gastric epithelial tumors (adenoma or gastric cancer)
CA2817957C (en) * 2010-11-15 2016-05-10 Texas Tech University Substance for increasing the production of a specific acyl-chain dihydroceramide(s) for improving the effectiveness of cancer treatments
AU2019342421B2 (en) * 2018-09-21 2024-09-05 Société des Produits Nestlé S.A. Compositions and methods for treatment of exocrine pancreatic insufficiency (EPI)
WO2025148196A1 (zh) * 2024-01-12 2025-07-17 小藻科技(安吉)有限公司 一种促进脂肪酸吸收及跨越血脑屏障的微藻提取物及其组合物的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874795A (en) * 1985-04-02 1989-10-17 Yesair David W Composition for delivery of orally administered drugs and other substances
US4849132A (en) 1986-05-16 1989-07-18 Asahi Denka Kogyo Kabushiki Kaisha Surfactant composition having improved functions
US5571517A (en) 1990-08-13 1996-11-05 Yesair; David W. Mixed lipid-bicarbonate colloidal particles for delivering drugs or calories
ES2071332T3 (es) 1990-08-13 1995-06-16 David W Yesair Particulas coloidales de lipidos mixtos-bicarbonato para administrar farmacos o calorias.
US5302400A (en) * 1992-06-22 1994-04-12 Digestive Care Inc. Preparation of gastric acid-resistant microspheres containing digestive enzymes and buffered-bile acids
JPH08143469A (ja) * 1994-11-14 1996-06-04 Amano Pharmaceut Co Ltd 膵外分泌機能不全症治療剤
JPH11506780A (ja) * 1995-06-06 1999-06-15 バイオモレキュラー プロダクツ,インク. 薬またはカロリー送達用の混合脂質−重炭酸塩コロイド粒子
US5716814A (en) 1996-02-02 1998-02-10 Biomolecular Products, Inc. Methods for making lysophosphatidylcholine
WO1998010776A1 (en) * 1996-09-11 1998-03-19 Shanahan Prendergast Elizabeth Therapeutic formulations containing venom or venom anti-serum either alone or in combination for the therapeutic prophylaxis and therapy of neoplasms

Also Published As

Publication number Publication date
DE69934325D1 (de) 2007-01-18
US6426069B1 (en) 2002-07-30
WO2000013689A1 (en) 2000-03-16
ZA200102268B (en) 2001-09-19
EP1119360A4 (en) 2003-06-04
CN1321089A (zh) 2001-11-07
IL141801A (en) 2009-02-11
CA2343116C (en) 2008-11-18
NO20011173D0 (no) 2001-03-07
JP4700193B2 (ja) 2011-06-15
JP2002524417A (ja) 2002-08-06
NZ510536A (en) 2003-07-25
NO20011173L (no) 2001-05-08
EP1119360B1 (en) 2006-12-06
CA2343116A1 (en) 2000-03-16
EP1119360A1 (en) 2001-08-01
AU771901B2 (en) 2004-04-08
AU5705299A (en) 2000-03-27
IL141801A0 (en) 2002-03-10
DE69934325T2 (de) 2007-07-05

Similar Documents

Publication Publication Date Title
BR9909502A (pt) Processo para redução do teor de componentes contendo fósforo em um óleo edìvel
BR9809793A (pt) Monoésteres de probucol para o tratamento de doença inflamatória e cardiovascular
DE69504184D1 (de) Neue kationische phospholipide zur transfektion
ATE347371T1 (de) Zusammenstellungen zur erhöhung der darmabsoption von fetten
IL138476A0 (en) Method for treating pharmaceutical compositions by special use of anti-oxidant
BR9915679A (pt) Composições e métodos para aumentar a mineralização óssea
TR200000927T2 (tr) Prostaglandin agonistleri ve kemik bozukluklarının tedavisi
DE59800221D1 (de) Verfahren zur Stabilisierung von Retinol bzw. Retinol-Derivaten
ATE247666T1 (de) Wasserlöslische prodrugs von 2,6- diisopropylphenol-analoga
DK1663185T3 (da) Forebyggelse og behandling af inflammationsinduceret og/eller immun-medieret knogletab
BR9914044A (pt) ésteres tetrahidropirido
DE60023870D1 (de) Verfahren zur herstellung von 3-aryloxy-3-arylpropylamine und deren zwischenprodukte
DE69635304D1 (de) Faenger fuer oxidantien
DE69628489D1 (de) Verfahren zur Herstellung von RTV-Einkomponenten-Siliconelastomerzusammensetzungen
FR2834889B1 (fr) Forme pharmaceutique solide orodispersible
BRPI0309421B8 (pt) método de preparar um gênero alimentício e composição para tratar ou prevenir hipercolesterolemia
DE69821300D1 (de) Verfahren zur Herstellung alkoholstabiler (Mikro-) Emulsionen
DE69935509D1 (de) Verfahren zur herstellung von durchscheinenden zahnersätzen
BR0309406A (pt) Composição farmacêutica, processo de preparação, kit e métodos para tratamento de obesidade, utilização de composição e inibidor de lìpases, inibidor de lìpáses e glucomanan ou konjac e utilização dos mesmos e método de tratamento
DE69916148T2 (de) Verfahren zur Herstellung von RTV-Organopolysiloxan-Zusammensetzungen
ES2156105T3 (es) Derivados de amino-fenoles sustituidos en n y o, productos intermedios para su preparacion, su utilizacion como substratos para hidrolasas, un correspondiente procedimiento de determinacion y un agente de diagnostico apropiado para ello.
DE69730796D1 (de) Naphthylverbindungen, Zusammensetzungen und Verfahren
ATE247101T1 (de) Benzothiophenderivate, zwischenprodukte, verfahren, zubereitungen und methoden
DE59900916D1 (de) Verfahren zur Herstellung von 4-Aminodiphenylamin
ES2163634T3 (es) Benzopiranos y composiciones farmaceuticas que les contienen.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties